Company & Sponsor Intelligence

University of Pittsburgh

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials19

Recruiting4

Completed15

Countries1

Therapeutic footprint

alzheimersanxietyautismdepressionschizophreniastroke

Indexed studies

NCT03432832Emotion Awareness and Skills Enhancement Program
autism · United StatesNA

NCT05256095Thinking in Speech for Children With Autism
autism · United StatesNA

NCT03170453Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
autism · United StatesNA

NCT06603064Neuromodulation of Brain and Emotional Responses to Psychological Stress
anxiety · United StatesNA

NCT00177177L-carnosine for Schizophrenia
schizophrenia · United StatesNA

NCT00177671Antidepressant Medication Plus Donepezil for Treating Late-life Depression
alzheimers · United StatesPHASE4

NCT06386029The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol
autism · United StatesNA

NCT01303133Natural History of Amyloid Deposition in Adults With Down Syndrome
alzheimers · United StatesCOMPLETED

NCT06191484Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
depression · United StatesNA

NCT07476937Differences in Rest, Emotion, and Arousal Modulation in Youth
autism · United StatesNA

NCT00051207Therapy for Depression With Co-occurring Panic or Anxiety Symptoms
depression · United StatesPHASE1, PHASE2

NCT03305731Activating Behavior for Lasting Engagement After Stroke
stroke · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →